$10.690
+0.122 (+1.14%)Zum Schluss
TLX im Vergleich zur Peergroup
In the context of the broader market, TLX competes directly with industry leaders such as KOD and CGON. With a market capitalization of $3.69B, it holds a significant position in the sector. When comparing efficiency, TLX's gross margin of N/A stands against KOD's N/A and CGON's -239.24%. Such benchmarking helps identify whether Telix Pharmaceuticals Limited is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Telix Pharmaceuticals Ltd
The stock has a high forward P/E of 140.85 and a current price of $10.69, with a recent 5-day change of -4.64%.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.